Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elite Health Systems Inc.EHSI · Entity 7531 | Director | August 06, 2025 | August 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elite Health Systems Inc.
Report date August 06, 2025 · Filed August 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2025 Equity Incentive PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.95 · Expires 2035-08-06 | Direct | 25,000 |
Reported balance
After 2025-08-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 25,000 · Balance 25,000 F1: NA |
Filing footnotes · ownership attribution and instrument terms
F1: NA
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2025 Filed Aug 8, 2025 20:53 UTC | Elite Health Systems Inc. EHSI · Entity 7531 | Grant2025 Equity Incentive Plan · Derivative | 25,000 | Not disclosed Strike: $0.95 | Not disclosed |
DisclosureSEC source: 0001437749-25-025760 · rdgdoc.xml · derivative · entry 1 Gold Alan · CIK 0001540550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: common stock · 25,000 shares Expires 2035-08-06 F1 · price: NA Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.